Here’s why I’d buy these FTSE 250 stocks near 52-week lows

Could now be great time to buy into some underpriced FTSE 250 stocks ahead of the next mid-cap bull run? I think it just might.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I have good feelings about the FTSE 250, as the mid-cap index typically climbs ahead of the FTSE 100 when the market’s in a bullish mood.

The bulls aren’t exactly running right now, I know. But as inflation data improves and interest rates come down further, I reckon the chances of a new surge could grow by the day.

Biotech resurgence?

And that’s when I think stocks like PureTech Health (LSE: PRTC) could start to shine once more.

This is a biotech business. And at the end of the last full year, the firm spoke of its “broad and deep pipeline”, and reminded us that it has as many as “29 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval”.

PureTech stock’s had a bad year, as the appetite for smaller-cap growth stocks has faded. The new dip that kicked off in June hasn’t pushed the stock down quite as far as the 52-week low it set in December 2023. But we’re not far above it.

The road to profit

The key risk, as with so many similar stocks to this, is that there’s no profit yet. But forecasts at least see revenue starting to ramp up in 2025. And there seems to be plenty of cash on the books. As of December 2023, the company had “cash equivalents and short-term investments of $326m”.

As the economic clouds clear and investors are drawn back in to the stock market, I think we might see renewed growth stock sentiment. I’m very tempted to take the risk and go in with a small amount of cash. First-half results are due on 28 August.

Grounded airline

I don’t usually buy airline stocks. But Wizz Air’s (LSE: WIZZ) tanked in the past month, and it’s only slightly back up from its 52-week low.

In this case, the drop’s all down to Q1 earnings released on 1 August. The company revealed a crushing 98% fall in net profit, to just €1.2m.

CEO József Váradi spoke of “the resilience of Wizz Air’s ultra-low-cost business model.” I’m not entirely sure how such a huge profit fall can be a sign of anything positive, mind.

On the deck

Still, the problem looks to me to be a fairly short-term one. It’s all about plane groundings due to issues with the firm’s Pratt & Whitney GTF engines. At Q1 results time, the airline had 46 of its 179 aircraft firmly stuck on the ground. There’s going to be some compensation, which will help.

There’s intense competition in this business. And Wizz’s coming under pricing pressure, which I think it might have a bit of a struggle with.

But it still looks oversold to me. And this is another FTSE 250 stock I might buy a bit of when I have my next lot of investment cash ready.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

If I’d put £20k into the FTSE 250 1 year ago, here’s what I’d have today!

The FTSE 250 has outperformed the bigger FTSE 100 over the last year. Roland Head highlights a mid-cap share to…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Growth Shares

The Scottish Mortgage share price is smashing the FTSE 100 again

Year to date, the Scottish Mortgage share price has risen far more than the Footsie has. Edward Sheldon expects this…

Read more »

Investing Articles

As H1 results lift the Land Securities share price, should I buy?

An improving full-year outlook could give the Land Securities share price a boost. But economic pressures on REITs are still…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

How much are Rolls-Royce shares really worth as we approach 2025?

After starting the year at 300p, Rolls-Royce shares have climbed to 540p. But are they really worth that much? Edward…

Read more »

Investing Articles

Despite rocketing 33% this hidden FTSE 100 gem is still dirt cheap with a P/E under 5!

Harvey Jones has been tracking this under -the-radar FTSE 100 growth stock for some time. He thinks it looks a…

Read more »

Dividend Shares

How I could earn a juicy second income starting with just £250

Jon Smith explains how investing a regular amount each month in dividend stocks with above average yields can build a…

Read more »

Young female hand showing five fingers.
Investing Articles

If I’d put £10,000 into the FTSE 250 5 years ago, here’s how much I’d have now!

The FTSE 250 hasn’t done well over the past five years. But by being selective about which of its stocks…

Read more »

Senior woman wearing glasses using laptop at home
Investing Articles

With UK share prices dipping, I’m considering two opportunities in penny stocks

A market dip has presented opportunities in UK shares, particularly in cheap penny stocks. With bargain prices across the board,…

Read more »